Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • News & Views
  • Published:

UNDIFFERENTIATED ARTHRITIS

The undifferentiated arthritis dilemma: the story continues

Nature Reviews Rheumatology volume 18, pages 189–190 (2022)Cite this article

Subjects

Undifferentiated arthritis (UA) was redefined by the introduction of the 2010 rheumatoid arthritis (RA) classification criteria. But UA is more than just not having RA — it is about selecting the right patients for DMARD treatment even before diagnosis, and about protecting those with self-limiting disease from potential drug toxicity.

This is a preview of subscription content, access via your institution

Relevant articles

Open Access articles citing this article.

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

References

  1. Verstappen, M., Matthijssen, X. M. E. & van der Helm-van Mil, A. H. M. Undifferentiated arthritis; a changing population who did not benefit from enhanced DMARD-strategies-results from a 25-years longitudinal inception cohort. Rheumatology https://doi.org/10.1093/rheumatology/keab880 (2021).

    Article  PubMed  PubMed Central  Google Scholar 

  2. Hazlewood, G. et al. Algorithm for identification of undifferentiated peripheral inflammatory arthritis: a multinational collaboration through the 3e initiative. J. Rheumatol. Suppl. 87, 54–58 (2011).

    Article  Google Scholar 

  3. van Nies, J. A. B., Tsonaka, R., Gaujoux-Viala, C., Fautrel, B. & van der Helm-van Mil, A. H. M. Evaluating relationships between symptom duration and persistence of rheumatoid arthritis: does a window of opportunity exist? Results on the Leiden early arthritis clinic and ESPOIR cohorts. Ann. Rheum. Dis. 74, 806–812 (2015).

    Article  Google Scholar 

  4. van der Linden, M. P. M. et al. Long-term impact of delay in assessment of patients with early arthritis. Arthritis Rheum. 62, 3537–3546 (2010).

    Article  Google Scholar 

  5. Combe, B. et al. 2016 update of the EULAR recommendations for the management of early arthritis. Ann. Rheum. Dis. 76, 948–959 (2017).

    Article  Google Scholar 

  6. van Aken, J. et al. Five-year outcomes of probable rheumatoid arthritis treated with methotrexate or placebo during the first year (the PROMPT study). Ann. Rheum. Dis. 73, 396–400 (2014).

    Article  Google Scholar 

  7. Aletaha, D. et al. 2010 rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative. Ann. Rheum. Dis. 69, 1580–1588 (2010).

    Article  Google Scholar 

  8. Aggarwal, R. et al. Distinctions between diagnostic and classification criteria? Arthritis Care Res. 67, 891–897 (2015).

    Article  Google Scholar 

  9. Mankia, K. et al. EULAR points to consider for conducting clinical trials and observational studies in individuals at risk of rheumatoid arthritis. Ann. Rheum. Dis. https://doi.org/10.1136/annrheumdis-2021-220884 (2021).

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Division of Rheumatology, Medical University Vienna, Vienna, Austria

    Daniel Aletaha

Authors
  1. Daniel Aletaha
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Daniel Aletaha.

Ethics declarations

Competing interests

The author declares no competing interests.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Aletaha, D. The undifferentiated arthritis dilemma: the story continues. Nat Rev Rheumatol 18, 189–190 (2022). https://doi.org/10.1038/s41584-022-00762-y

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/s41584-022-00762-y

This article is cited by

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing